BICYCLE THERAPEUTICS PLC-ADR
BCYCNASDAQ🏆 #3519 by market capEarnings Oct 28US Equity
$3.75▲ $0.10 (+2.60%)
LiveTrack BCYC
Get earnings, price moves & breaking news on Telegram
24h▲ 2.6%
7d▲ 4.2%
14d▲ 2.7%
30d▼ 9.5%
ytd▼ 46.9%
1y▼ 51.6%
🏦Market Cap
$260M
Small Cap
📈Revenue Growth (YoY)
+105.8%
High Growth
📊Gross Margin
100.0%
High
💵FCF Margin
-335.9%
Thin
⚖️P/S Ratio
4.3x
Fair
Otter Score
72
Fair
BICYCLE THERAPEUTICS PLC-ADR
BCYCAnalyst Ratings
Price
$3.75
Total
21
Raised
1
Lowered
0
Avg PT
$12.00
H / L
$12 / $12
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Needham | Reiterated | Buy | 2026-07-30 | — | — |
Morgan Stanley | Reiterated | Equal Weight | 2026-04-08 | $12.00 | +220.40% |
Oppenheimer | Reiterated | Outperform | 2026-03-18 | $48.00 | +1181.70% |
Citizens | Reiterated | Market Outperform | 2026-03-18 | — | — |
RBC Capital | Reiterated | Sector Perform | 2026-03-18 | $11.00 | +193.70% |
JMP Securities | Reiterated | Market Outperform | 2025-08-12 | $12.00 | +220.40% |
B. Riley Securities | Reiterated | Neutral | 2025-05-02 | — | — |
Barclays | Reiterated | Overweight | 2025-05-01 | — | — |
Citizens Capital Markets | Reiterated | Market Outperform | 2025-02-26 | — | — |
HC Wainwright & Co. | Reiterated | Buy | 2025-02-26 | — | — |
Stephens & Co. | Reiterated | Equal Weight | 2025-01-22 | — | — |
Canaccord Genuity | Reiterated | Buy | 2024-02-21 | — | — |
Cantor Fitzgerald | Reiterated | Overweight | 2023-11-08 | — | — |
EF Hutton | Reiterated | Buy | 2023-04-19 | — | — |
Cowen & Co. | Reiterated | Outperform | 2022-08-31 | — | — |
SVB Leerink | Reiterated | Outperform | 2022-08-22 | — | — |
Piper Sandler | Reiterated | Overweight | 2022-05-23 | $76.00 | +1929.40% |
Roth Capital | Reiterated | Buy | 2019-11-14 | $65.00 | +1635.60% |
Goldman Sachs | Upgraded | Neutral → Buy | 2019-09-11 | — | — |
Jefferies | Reiterated | Buy | 2019-06-17 | $12.00 | +220.40% |
Piper Jaffray | Reiterated | Overweight | 2019-06-17 | — | — |
Institution
Needham
Reiterated · Buy · 2026-07-30
—
—
Morgan Stanley
Reiterated · Equal Weight · 2026-04-08
$12.00
+220.40%
Oppenheimer
Reiterated · Outperform · 2026-03-18
$48.00
+1181.70%
Citizens
Reiterated · Market Outperform · 2026-03-18
—
—
RBC Capital
Reiterated · Sector Perform · 2026-03-18
$11.00
+193.70%
JMP Securities
Reiterated · Market Outperform · 2025-08-12
$12.00
+220.40%
B. Riley Securities
Reiterated · Neutral · 2025-05-02
—
—
Barclays
Reiterated · Overweight · 2025-05-01
—
—
Citizens Capital Markets
Reiterated · Market Outperform · 2025-02-26
—
—
HC Wainwright & Co.
Reiterated · Buy · 2025-02-26
—
—
Stephens & Co.
Reiterated · Equal Weight · 2025-01-22
—
—
Canaccord Genuity
Reiterated · Buy · 2024-02-21
—
—
Cantor Fitzgerald
Reiterated · Overweight · 2023-11-08
—
—
EF Hutton
Reiterated · Buy · 2023-04-19
—
—
Cowen & Co.
Reiterated · Outperform · 2022-08-31
—
—
SVB Leerink
Reiterated · Outperform · 2022-08-22
—
—
Piper Sandler
Reiterated · Overweight · 2022-05-23
$76.00
+1929.40%
Roth Capital
Reiterated · Buy · 2019-11-14
$65.00
+1635.60%
Goldman Sachs
Upgraded · Neutral → Buy · 2019-09-11
—
—
Jefferies
Reiterated · Buy · 2019-06-17
$12.00
+220.40%
Piper Jaffray
Reiterated · Overweight · 2019-06-17
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space